引 致 更 改 给 病 人 的 产 品 资 讯 的 药 物 不 良 反 应 警 示
|
| |
| The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): updated safety and educational materials to support patient discussion on reproductive risks (English only) |
| |
| |
| |
|
| Related Information: | | European Union: PRAC assessing new data on potential risk of neurodevelopmental ... 上载于 2025-07-12 | | Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronos... 上载于 2025-06-11 | | Australia: Potential risk of neurodevelopmental disorders in children born to me... 上载于 2025-03-07 | | The United Kingdom: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epil... 上载于 2025-02-14 | | The United Kingdom: Valproate use in men: as a precaution, men and their partner... 上载于 2024-09-06 | | European Union: Precautionary measures to address potential risk of neurodevelop... 上载于 2024-01-27 | | Singapore: Epilim® (valproate): Updates and new measures relating to the risk of... 上载于 2024-01-24 | | European Union: Potential risk of neurodevelopmental disorders in children born ... 上载于 2024-01-13 | | The United Kingdom: MHRA instructs health organisations to prepare now for new m... 上载于 2023-11-30 | | The United Kingdom: Valproate: re-analysis of study on risks in children of men ... 上载于 2023-08-31 | | European Union: EMA review of data on paternal exposure to valproate (English on... 上载于 2023-08-17 | | The United Kingdom: Safety of valproate – new study on risks in children of men ... 上载于 2023-08-17 | | Singapore: Epilim® (valproate): Risk of neurodevelopmental disorders including a... 上载于 2023-03-22 | | Epilim® (valproate) - Risk of neurodevelopmental disorders including autism spec... 上载于 2023-03-22 | | The United Kingdom: Valproate: reminder of current Pregnancy Prevention Programm... 上载于 2022-12-13 | | Valproate: MHRA's reminder of current Pregnancy Prevention Programme requirement... 上载于 2022-12-13 | | 台湾：公告修订含valproate类成分药品用于妇女的使用原则 上载于 2019-06-24 | | Singapore: Epilim® (valproate) – New restrictions on use (English Only) 上载于 2018-10-30 | | United Kingdom : Valproate Pregnancy Prevention Programme: actions required now ... 上载于 2018-09-26 | | Singapore: Valproate-containing medicines and risk of teratogenicity – An update... 上载于 2018-09-19 | | 英国：丙戊酸盐药物：除非符合预防怀孕计划的条件，否则具生育能力的女性禁用 上载于 2018-04-25 | | 欧洲联盟及英国：有关在怀孕期间使用丙戊酸盐药物的风险资讯及通过新措施避免怀孕期间暴露于丙戊酸盐：成员国代表同意新的使用限制和怀孕预防计划。 上载于 2018-03-24 | | 新加坡：Epilim® (丙戊酸盐) – 曾在子宫内接触丙戊酸盐的先天性畸形及儿童严重发育障碍的风险 上载于 2018-03-16 | | PRAC recommends new measures to avoid valproate exposure in pregnancy. New restr... 上载于 2018-02-12 | | 欧洲联盟：药物警戒风险评估委员会建议采取新措施避免怀孕期间暴露于丙戊酸盐。新使用限制; 怀孕预防计划落实执行。 上载于 2018-02-10 | | 英国：丙戊酸盐和发育失调：新警报导致病人审查及进一步考虑风险最小化措施 上载于 2017-04-25 | | 欧洲联盟：对怀孕和怀孕年龄妇女使用丙戊酸盐的新评审 - 欧洲药物监管局考虑这些药物的风险以评估是否需要进一步限制使用 上载于 2017-03-13 | | 欧洲联盟：更新对丙戊及相关物质的持续检讨 上载于 2014-07-14 | |
